PathoQuest

Why PARTNER WITH PathoQuest?

At PathoQuest, we understand the critical need to develop your innovative biopharmaceuticals safely and rapidly in a complex biosafety testing environment. PathoQuest provides a validated Next Generation Sequencing (NGS) approach in biosafety testing, biopharmaceuticals characterization, and release for global companies and emerging biopharma companies.

With a proven track record in biotesting, PathoQuest offers a team of NGS Quality Control (QC) testing experts based in France and the U.S. Our expert Contract Research Organization (CRO) team is readily available to support with rapid and robust QC testing at both GMP and non-GMP levels, emphasizing our commitment to biosafety services.

Let’s work together to transform the future of biotherapies and make a significant impact on patient lives.